Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer
- Autores
- Parker, B. S.; Ciocca, Daniel Ramon; Bidwell, B. N.; Gago, Francisco Eduardo; Fanelli, Mariel Andrea; George, J.; Slavin, J. L.; Möller, A.; Steel, R.; Pouliot, N.; Eckhardt, B. L.; Henderson, M. A.; Anderson, R. L.
- Año de publicación
- 2008
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Using the clinically relevant 4T1-derived syngeneic murine model of spontaneous mammary metastasis to bone, we have identified the cysteine cathepsin inhibitor Stefin A as a gene differentially expressed in primary and metastatic mammary tumours. In primary tumours, Stefin A expression correlated inversely with metastatic potential in 4T1-derived lines and was not detected in tumour cells in culture, indicating induction only within the tumour microenvironment. Enforced expression of Stefin A in the highly metastatic 4T1.2 cell line significantly reduced spontaneous bone metastasis following orthotopic injection into the mammary gland. Consistent with the mouse data, Stefin A expression correlated with disease-free survival (absence of distant metastasis) in a cohort of 142 primary tumours from breast cancer patients. This was most significant for patients with invasive ductal carcinoma expressing Stefin A, who were less likely to develop distant metastases (log rank test, p = 0.0075). In a multivariate disease-free survival analysis (Cox proportional hazards model), Stefin A expression remained a significant independent prognostic factor in patients with invasive ductal carcinoma (p = 0.0014), along with grade and progesterone receptor (PR) status. In human lung and bone metastases, we detected irregular Stefin A staining patterns, with expression often localizing to micrometastases (<0.2 mm) in direct contact with the stroma. We propose that Stefin A, as a cysteine cathepsin inhibitor, may be a marker of increased cathepsin activity in metastases. Using immunohistology, the cathepsin inhibitor was detected co-expressed with cathepsin B in lung and bone metastases in both the murine model and human tissues. We conclude that Stefin A expression reduces distant metastasis in breast cancer and propose that this may be due to the inhibition of cysteine cathepsins, such as cathepsin B.
Fil: Parker, B. S.. University of Melbourne; Australia
Fil: Ciocca, Daniel Ramon. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina
Fil: Bidwell, B. N.. University of Melbourne; Australia
Fil: Gago, Francisco Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina
Fil: Fanelli, Mariel Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina
Fil: George, J.. Peter MacCallum Cancer Centre; Australia
Fil: Slavin, J. L.. University of Melbourne; Australia
Fil: Möller, A.. Peter MacCallum Cancer; Australia. , University of Melbourne; Australia
Fil: Steel, R.. Peter MacCallum Cancer; Australia. University of Melbourne; Australia
Fil: Pouliot, N.. Peter MacCallum Cancer; Australia. University of Melbourne; Australia
Fil: Eckhardt, B. L.. Peter MacCallum Cancer; Australia. University of Melbourne; Australia
Fil: Henderson, M. A.. Peter MacCallum Cancer; Australia
Fil: Anderson, R. L.. Peter MacCallum Cancer; Australia. University of Melbourne; Australia - Materia
-
BONE METASTASIS
BREAST CANCER
CYSTEINE CATHEPSINS
STEFIN A - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/130099
Ver los metadatos del registro completo
id |
CONICETDig_86ff048e27132762e3e1dcd16c7a3dbb |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/130099 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancerParker, B. S.Ciocca, Daniel RamonBidwell, B. N.Gago, Francisco EduardoFanelli, Mariel AndreaGeorge, J.Slavin, J. L.Möller, A.Steel, R.Pouliot, N.Eckhardt, B. L.Henderson, M. A.Anderson, R. L.BONE METASTASISBREAST CANCERCYSTEINE CATHEPSINSSTEFIN Ahttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Using the clinically relevant 4T1-derived syngeneic murine model of spontaneous mammary metastasis to bone, we have identified the cysteine cathepsin inhibitor Stefin A as a gene differentially expressed in primary and metastatic mammary tumours. In primary tumours, Stefin A expression correlated inversely with metastatic potential in 4T1-derived lines and was not detected in tumour cells in culture, indicating induction only within the tumour microenvironment. Enforced expression of Stefin A in the highly metastatic 4T1.2 cell line significantly reduced spontaneous bone metastasis following orthotopic injection into the mammary gland. Consistent with the mouse data, Stefin A expression correlated with disease-free survival (absence of distant metastasis) in a cohort of 142 primary tumours from breast cancer patients. This was most significant for patients with invasive ductal carcinoma expressing Stefin A, who were less likely to develop distant metastases (log rank test, p = 0.0075). In a multivariate disease-free survival analysis (Cox proportional hazards model), Stefin A expression remained a significant independent prognostic factor in patients with invasive ductal carcinoma (p = 0.0014), along with grade and progesterone receptor (PR) status. In human lung and bone metastases, we detected irregular Stefin A staining patterns, with expression often localizing to micrometastases (<0.2 mm) in direct contact with the stroma. We propose that Stefin A, as a cysteine cathepsin inhibitor, may be a marker of increased cathepsin activity in metastases. Using immunohistology, the cathepsin inhibitor was detected co-expressed with cathepsin B in lung and bone metastases in both the murine model and human tissues. We conclude that Stefin A expression reduces distant metastasis in breast cancer and propose that this may be due to the inhibition of cysteine cathepsins, such as cathepsin B.Fil: Parker, B. S.. University of Melbourne; AustraliaFil: Ciocca, Daniel Ramon. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Bidwell, B. N.. University of Melbourne; AustraliaFil: Gago, Francisco Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Fanelli, Mariel Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: George, J.. Peter MacCallum Cancer Centre; AustraliaFil: Slavin, J. L.. University of Melbourne; AustraliaFil: Möller, A.. Peter MacCallum Cancer; Australia. , University of Melbourne; AustraliaFil: Steel, R.. Peter MacCallum Cancer; Australia. University of Melbourne; AustraliaFil: Pouliot, N.. Peter MacCallum Cancer; Australia. University of Melbourne; AustraliaFil: Eckhardt, B. L.. Peter MacCallum Cancer; Australia. University of Melbourne; AustraliaFil: Henderson, M. A.. Peter MacCallum Cancer; AustraliaFil: Anderson, R. L.. Peter MacCallum Cancer; Australia. University of Melbourne; AustraliaJohn Wiley & Sons Ltd2008-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/130099Parker, B. S.; Ciocca, Daniel Ramon; Bidwell, B. N.; Gago, Francisco Eduardo; Fanelli, Mariel Andrea; et al.; Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer; John Wiley & Sons Ltd; Journal of Pathology; 214; 3; 10-2008; 337-3460022-3417CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1002/path.2265info:eu-repo/semantics/altIdentifier/doi/10.1002/path.2265info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:49:03Zoai:ri.conicet.gov.ar:11336/130099instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:49:04.145CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer |
title |
Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer |
spellingShingle |
Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer Parker, B. S. BONE METASTASIS BREAST CANCER CYSTEINE CATHEPSINS STEFIN A |
title_short |
Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer |
title_full |
Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer |
title_fullStr |
Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer |
title_full_unstemmed |
Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer |
title_sort |
Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer |
dc.creator.none.fl_str_mv |
Parker, B. S. Ciocca, Daniel Ramon Bidwell, B. N. Gago, Francisco Eduardo Fanelli, Mariel Andrea George, J. Slavin, J. L. Möller, A. Steel, R. Pouliot, N. Eckhardt, B. L. Henderson, M. A. Anderson, R. L. |
author |
Parker, B. S. |
author_facet |
Parker, B. S. Ciocca, Daniel Ramon Bidwell, B. N. Gago, Francisco Eduardo Fanelli, Mariel Andrea George, J. Slavin, J. L. Möller, A. Steel, R. Pouliot, N. Eckhardt, B. L. Henderson, M. A. Anderson, R. L. |
author_role |
author |
author2 |
Ciocca, Daniel Ramon Bidwell, B. N. Gago, Francisco Eduardo Fanelli, Mariel Andrea George, J. Slavin, J. L. Möller, A. Steel, R. Pouliot, N. Eckhardt, B. L. Henderson, M. A. Anderson, R. L. |
author2_role |
author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
BONE METASTASIS BREAST CANCER CYSTEINE CATHEPSINS STEFIN A |
topic |
BONE METASTASIS BREAST CANCER CYSTEINE CATHEPSINS STEFIN A |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Using the clinically relevant 4T1-derived syngeneic murine model of spontaneous mammary metastasis to bone, we have identified the cysteine cathepsin inhibitor Stefin A as a gene differentially expressed in primary and metastatic mammary tumours. In primary tumours, Stefin A expression correlated inversely with metastatic potential in 4T1-derived lines and was not detected in tumour cells in culture, indicating induction only within the tumour microenvironment. Enforced expression of Stefin A in the highly metastatic 4T1.2 cell line significantly reduced spontaneous bone metastasis following orthotopic injection into the mammary gland. Consistent with the mouse data, Stefin A expression correlated with disease-free survival (absence of distant metastasis) in a cohort of 142 primary tumours from breast cancer patients. This was most significant for patients with invasive ductal carcinoma expressing Stefin A, who were less likely to develop distant metastases (log rank test, p = 0.0075). In a multivariate disease-free survival analysis (Cox proportional hazards model), Stefin A expression remained a significant independent prognostic factor in patients with invasive ductal carcinoma (p = 0.0014), along with grade and progesterone receptor (PR) status. In human lung and bone metastases, we detected irregular Stefin A staining patterns, with expression often localizing to micrometastases (<0.2 mm) in direct contact with the stroma. We propose that Stefin A, as a cysteine cathepsin inhibitor, may be a marker of increased cathepsin activity in metastases. Using immunohistology, the cathepsin inhibitor was detected co-expressed with cathepsin B in lung and bone metastases in both the murine model and human tissues. We conclude that Stefin A expression reduces distant metastasis in breast cancer and propose that this may be due to the inhibition of cysteine cathepsins, such as cathepsin B. Fil: Parker, B. S.. University of Melbourne; Australia Fil: Ciocca, Daniel Ramon. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina Fil: Bidwell, B. N.. University of Melbourne; Australia Fil: Gago, Francisco Eduardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina Fil: Fanelli, Mariel Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina Fil: George, J.. Peter MacCallum Cancer Centre; Australia Fil: Slavin, J. L.. University of Melbourne; Australia Fil: Möller, A.. Peter MacCallum Cancer; Australia. , University of Melbourne; Australia Fil: Steel, R.. Peter MacCallum Cancer; Australia. University of Melbourne; Australia Fil: Pouliot, N.. Peter MacCallum Cancer; Australia. University of Melbourne; Australia Fil: Eckhardt, B. L.. Peter MacCallum Cancer; Australia. University of Melbourne; Australia Fil: Henderson, M. A.. Peter MacCallum Cancer; Australia Fil: Anderson, R. L.. Peter MacCallum Cancer; Australia. University of Melbourne; Australia |
description |
Using the clinically relevant 4T1-derived syngeneic murine model of spontaneous mammary metastasis to bone, we have identified the cysteine cathepsin inhibitor Stefin A as a gene differentially expressed in primary and metastatic mammary tumours. In primary tumours, Stefin A expression correlated inversely with metastatic potential in 4T1-derived lines and was not detected in tumour cells in culture, indicating induction only within the tumour microenvironment. Enforced expression of Stefin A in the highly metastatic 4T1.2 cell line significantly reduced spontaneous bone metastasis following orthotopic injection into the mammary gland. Consistent with the mouse data, Stefin A expression correlated with disease-free survival (absence of distant metastasis) in a cohort of 142 primary tumours from breast cancer patients. This was most significant for patients with invasive ductal carcinoma expressing Stefin A, who were less likely to develop distant metastases (log rank test, p = 0.0075). In a multivariate disease-free survival analysis (Cox proportional hazards model), Stefin A expression remained a significant independent prognostic factor in patients with invasive ductal carcinoma (p = 0.0014), along with grade and progesterone receptor (PR) status. In human lung and bone metastases, we detected irregular Stefin A staining patterns, with expression often localizing to micrometastases (<0.2 mm) in direct contact with the stroma. We propose that Stefin A, as a cysteine cathepsin inhibitor, may be a marker of increased cathepsin activity in metastases. Using immunohistology, the cathepsin inhibitor was detected co-expressed with cathepsin B in lung and bone metastases in both the murine model and human tissues. We conclude that Stefin A expression reduces distant metastasis in breast cancer and propose that this may be due to the inhibition of cysteine cathepsins, such as cathepsin B. |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008-10 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/130099 Parker, B. S.; Ciocca, Daniel Ramon; Bidwell, B. N.; Gago, Francisco Eduardo; Fanelli, Mariel Andrea; et al.; Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer; John Wiley & Sons Ltd; Journal of Pathology; 214; 3; 10-2008; 337-346 0022-3417 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/130099 |
identifier_str_mv |
Parker, B. S.; Ciocca, Daniel Ramon; Bidwell, B. N.; Gago, Francisco Eduardo; Fanelli, Mariel Andrea; et al.; Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer; John Wiley & Sons Ltd; Journal of Pathology; 214; 3; 10-2008; 337-346 0022-3417 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1002/path.2265 info:eu-repo/semantics/altIdentifier/doi/10.1002/path.2265 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
John Wiley & Sons Ltd |
publisher.none.fl_str_mv |
John Wiley & Sons Ltd |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613521346658304 |
score |
13.070432 |